血脂康与洛伐他汀疗效对比观察

Clinical Contrasting Observation on Therapeutic Effect of Xuezhikang Capsules and Lovaststins

目的观察血脂康的调脂疗效。方法将原发性血脂异常患者92例随机分为两组，治疗组口服血脂康胶囊2粒／次，2次，d，8周为1疗程；对照组口服洛伐他汀胶囊20mg，1次/d，晚餐时服用，8周为1疗程。结果两组血脂水平改善及总有效率均无显著差异（P均〉0．05）。结论血脂康具有调节脂质代谢紊乱的作用，疗效较好。

Objective To evaluate the curative effect of Xuezhikang Capsules. Methods 92 cases of primary hyperlipidemia were randomly separated into experiment group and control group. Members in the experiment group were treated by Xuezhikang Capsules with 2 granules for one time and twice daily, lasting for 8 weeks. Members in the control group were treated by lovastatins after supper with 20mg for one time and once daily, lasting for 8 weeks, too. At the end of therapeutic courses, clinical efficacy of blood fat controlling was evaluated. Results There was no significant difference （P 〉0.05 ）between the two groups in terms of blood fat improvement and total effective rate. Conclusion Xuezhikang Capsules was effective in controlling hyperlipidemia.